Merck & Co., Inc. Case
If one hold a key to resolve a very serious problem, one has a responsibility to put an effort to make it happen, at least try one’s best. In this case, river blindness disease was a very serious problem, and Dr. Vagelos was the one who could make a decision as to whether the research and development of a human version of ivermectin should be carried on, then it was his responsibility to pursue it. Caused by a parasitic worm carried by a tiny black fly, the disease brought about visual impairment and skin lesions to millions of people. The World Health Organization (WHO) estimated in 1978 that some 340,000 people were blind because of onchocerciasis, and that a million more were suffered from various
…show more content…
In fact, Merck employees found the words inspirational. Setting a goal to alleviate the pain of millions of afflicted people in the Third World will consolidate the company’s culture and uplift employees’ morale. In addition to that, this is not the first time that the company will give something back to the community: Merck had already donated considerable quantities of streptomycin to Japan, which had faced especially high levels of tuberculosis in the aftermath of the World War II -- a philanthropy that was repeated in 1958 when the Merck Medical Outreach Program donated antibiotics, antiparasitic agents and vaccines for humanitarian efforts in developing countries and disaster zones (Rea, Zhang, & Baras, 2010) That is to say, if the company sees this program through, it will do a great service to the world once again. Second of all, the approval of the pursuit of the human version of ivermactin does not mean that he has to fund the program all at once or fund it with a big amount of money that will consequently affect other developments or other lines of production. The funding can be from the profits that the company made in the previous year. In fact, according to the case, annual net revenue has increased every year in the past ten years. The funding for this project can be some kind of a long-term plan. It is better to initiate the funding that last a long
This discussion question is based on a case study. As in all case studies, review the facts of the case and consider the various steps of the nursing process in order to address the critical thinking questions.
This report is Part 1 of assignment for Marketing MBA 565-MBOL1 to Dr. Stephen Baglione
Pharmed First Inc. is a widely successful chain pharmaceutical company with 85 drugstores located in Canada’s Atlantic provinces. George Brenner is one of the 6 regional managers and Angela MacFee is a store manager in a mall located in Dartmouth. One of MacFee’s loyal customers have purchased 9 packages of Diet Magic on September 2011 however wanted to return them on May 2012. Subsequently, MacFee reacted hastily and defensively, arguing with Johnston in spite of Pharmed First Inc. return policy (Figure 1). As a result, Johnston wrote a letter to Frank Chen, the president of Pharmed First Inc. and told Brenner to deal with it. He proposed that the company gives Johnston a $500 voucher and that MacFee apologizes. However, MacFee remained inflexible as she also challenged Brenner’s authority.
EXECUTIVE SUMMARYSilicon Valley Medical Technologies (SIVMED) was founded as a research and development firm. In the beginning, SIVMED performed its own basic research, obtained patents on promising technologies, and then either sold or licensed the technologies to other firms which marketed the products. The firm has since then grown and is now contracted to perform research and testing for larger genetic engineering firms, biotechnology firms, the US government, and is now widely recognized as the leader in an emerging growth industry. SIVMED's founders were relatively wealthy individuals when they started company, and they committed a great deal of their own funds to the venture. Their personal funds, however, were soon exhausted by the
seeking approval for Antegren, a drug that Biogen Idec was developing in partnership with Elan to
1) What significant changes have occurred in the Canadian mouthwash market in the past three years?
Merck is one of the biggest pharmaceutical companies in the world today. Although encountered with success, it still faces many problems today while trying to be the market leader competing against its competition. While being research and development driven company, Merck now has to go beyond R&D to stay competitive in the pharmaceutical industry. The main issue that seems to come up is that how far it can progress with the dual challenge of hitting peak annual financial performance while keeping the research pipeline full continued to weigh on senior management. Through the late 80s to early 90s, Merck was able to boast
This paper will research the Product recall involving the Drug Company known as Merck, who produced the drug Vioxx use to treat osteoarthritis, and acute pain in adults. Looking at the relationships Merck had with government and lobbyist one can see what actions the drug company may have taken to lead them to this recall. In Addition, This paper will look at the actions Merck took in the approval process and recall of their drug. Using all information provided on this case this paper will decide whether Merck was ethically correct in bringing the drug to market and if they took the right steps in recalling it. Finally I will discuss the other stakeholder responsibilities and provide solutions to prevent this from happening in the future.
The pharmaceutical industry includes companies that research, develop, market or distribute generic and branded drugs. The industry expanded during the 1980’s and drugs to treat heart disease and AIDS were prominent. Consumer demand for nutritional supplements and alternative medicine increased during the 1990’s with the Internet facilitating direct purchases of drugs. Advertising for direct consumption of pharmaceutical drugs became more prominent; pharmaceutical companies were criticized for over medicating personality or social problems.
Lorex Pharmaceuticals recently gained FDA approval to market and sell a new product called Linatol. This memo will address the need to select a target amount to which each 10-ounce bottle of Linatol will be filled. The analysis of several target fill rates was conducted to determine the one that maximizes the contribution per case, therefore generating the maximum revenue for Lorex Pharmaceuticals. This ideal fill rate will allow more bottles to be sold at the full retail price of $186 and limit the under filled
As consultant to Sanders and Myers, I would suggest they rethink the continuation of economic value added (“EVA”) bonus payout process. The proposed EVA bonus payout structure is supposed to be an objective way to gauge and reward employee performance; however, through no fault of their own, the Dermatology group is slated to undergo severe ebbs and flows in their incentive and could potentially wreak havoc on employee morale and retention.
Polyethylene is the world’s most widely used plastic. Polyethylene plastic’s principal application was in packaging, from trash bags to milk jugs. It was widely used in the manufacture of everything from trash bags, picnic cutlery and garbage pails, to plastic toys. Polyethylene also replaced glass, wood, and metal in certain applications.
Merck was established in 1891 to improve human and animal health through the development of innovative products. Merck currently has two reportable segments, the Pharmaceutical Segment and the Vaccines and Infectious Diseases Segment. Merck sells products through several channels including wholesalers, retailers, hospitals, clinics, government and managed health services providers. In the 1980’s the Merck was very successful in producing 10 major new drugs and had a very healthy pipeline. In later years, Merck has entered into joint ventures with many other pharmaceutical companies in order to expand its pipeline. In the last several years Merck has
As the brand manager for Allround cold medicine, there were many decisions regarding product formulation, strategy, line extensions and product launches over the company’s last 10 periods. The brand was focused on remaining a profitable, mature product family within the cold medicine category, but also maintaining a premium brand image.
Specify the types of country risks that pharmaceutical firms face in international business. How do the political and legal systems of countries affect the global pharmaceutical industry?